Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery.

Détails

ID Serval
serval:BIB_874F2DD77B06
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery.
Périodique
BMC ophthalmology
Auteur(s)
Andreanos K., Petrou P., Kymionis G., Papaconstantinou D., Georgalas I.
ISSN
1471-2415 (Electronic)
ISSN-L
1471-2415
Statut éditorial
Publié
Date de publication
06/12/2017
Peer-reviewed
Oui
Volume
17
Numéro
1
Pages
238
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: epublish
Résumé
We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment.
A 51-year-old female underwent uneventful cataract surgery with prophylactic intracameral vancomycin during the procedure. On the seventh post-operative-day, she presented with sudden painful, visual loss. Fundus examination revealed peripheral hemorrhagic retinal vasculitis. She received anti-VEGF therapy to prevent further vision loss and retinal neovascularization due to extensive retinal ischemia. At the 6-month follow-up visit, visual acuity was 20/20 with no sign of neovascularization.
Postoperative HORV is a devastating condition that can occur after otherwise uncomplicated cataract surgery. The nature of this rare condition remains unknown. Early anti-VEGF administration seems to demonstrate favorable results.

Mots-clé
Angiogenesis Inhibitors/therapeutic use, Bevacizumab/therapeutic use, Cataract Extraction, Eye Hemorrhage/drug therapy, Female, Humans, Middle Aged, Postoperative Complications/drug therapy, Retinal Vasculitis/drug therapy, Treatment Outcome, Vascular Endothelial Growth Factor A, Anti-VEGF, Cataract surgery, Hemorrhagic occlusive retinal vasculitis, Vancomycin
Pubmed
Web of science
Création de la notice
19/01/2018 10:38
Dernière modification de la notice
03/03/2018 19:01
Données d'usage